checkAd

     467  0 Kommentare Diabetes Injection Pens Market is Expected to be Worth US$9.7 Billion by 2024 - Leading Players Operating are Novo Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A - Seite 3

    Diabetes Devices and Drugs Market (Devices: Diagnostic & Monitoring and Insulin Delivery Devices, Drugs: Insulin Derivatives, GLP-1 and OADs) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
    http://www.transparencymarketresearch.com/diabetes-devices-market.html

    In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018

    http://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

    About Us: 

    Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact Us:
    Transparency Market Research
    90 State Street, Suite 700
    Albany, NY 12207
    Tel: +1-518-618-1030
    USA - Canada Toll Free: 866-552-3453
    Email: sales@transparencymarketresearch.com

    Website: http://www.transparencymarketresearch.com
    Blog: http://www.tmrblog.com/


    Seite 3 von 3



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Diabetes Injection Pens Market is Expected to be Worth US$9.7 Billion by 2024 - Leading Players Operating are Novo Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A - Seite 3 ALBANY, New York, December 8, 2016 /PRNewswire/ - According to the research report, the opportunity in the global Diabetes Injection Pens Market is expected to be worth US$9.7 bn by the end of 2024 as compared to US$4.9 bn in 2015. Between the …

    Schreibe Deinen Kommentar

    Disclaimer